Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xycrobe Therapeutics
San Diego, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Xycrobe technology has been integrated into Crown Laboratories' portfolio post-acquisition, with a 2022 study demonstrating efficacy in improving skin texture, tone, health, and appearance using patented Xycrobe strains[3][5][6].
- Therapeutic areas
- Dermatology
- Modalities
- Live biotherapeutic product therapyMicrobial therapy
- Industry
- Biotech
02
Partnerships
Janssen Human Microbiome Institute (JHMI)
Beyond the preview
Go deeper on Xycrobe Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xycrobe Therapeutics.